BrainStorm Cell Therapeutics Company
BrainStorm Cell Therapeutics is a biotechnology company developing autologous stem cell therapies for neurodegenerative diseases.
Total Funding:
$51.6M
Headquarters:
New York, New York, United States
Funding Status:
N/A
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Investment Stage:
N/A
Last Funding Type:
Grant
Number Of Exists:
Grant
Technology:
Regenerative Medicine
Investor Type:
Company
Investors Number:
5
Founded Date:
6-26
Industry:
Neuropharmacology